ONCOMINE analysis revealed that FoxM1 mRNA expression was significantly higher in a wide variety of datasets in different cancer types than corresponding normal samples, especially in sarcoma, lung cancer and breast cancer. This evidence concerns the gene FOXM1 and lung cancer.